Penn scientists use CRISPR for first time to correct clotting in newborn and adult mice
(PHILADELPHIA) - CRISPR/Cas9, a powerful genome editing tool, is showing promise for efficient correction of disease-causing mutations. For the first time, researchers from the Perelman...




